198 related articles for article (PubMed ID: 2068893)
1. Insulin resistance, but normal basal rates of glucose production in patients with newly diagnosed mild diabetes mellitus.
Hother-Nielsen O; Beck-Nielsen H
Acta Endocrinol (Copenh); 1991 Jun; 124(6):637-45. PubMed ID: 2068893
[TBL] [Abstract][Full Text] [Related]
2. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
[TBL] [Abstract][Full Text] [Related]
3. Glucose production, utilization, and cycling in response to moderate exercise in obese subjects with type 2 diabetes and mild hyperglycemia.
Giacca A; Groenewoud Y; Tsui E; McClean P; Zinman B
Diabetes; 1998 Nov; 47(11):1763-70. PubMed ID: 9792546
[TBL] [Abstract][Full Text] [Related]
4. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
6. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
7. Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients.
Pigon J; Giacca A; Ostenson CG; Lam L; Vranic M; Efendic S
J Clin Endocrinol Metab; 1996 Oct; 81(10):3702-8. PubMed ID: 8855826
[TBL] [Abstract][Full Text] [Related]
8. Assessment of hepatic insulin action in obese type 2 diabetic patients.
Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
[TBL] [Abstract][Full Text] [Related]
9. Does overnight normalization of plasma glucose by insulin infusion affect assessment of glucose metabolism in Type 2 diabetes?
Staehr P; Hojlund K; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabet Med; 2003 Oct; 20(10):816-22. PubMed ID: 14510862
[TBL] [Abstract][Full Text] [Related]
10. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
11. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM
Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435
[TBL] [Abstract][Full Text] [Related]
12. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
13. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
[TBL] [Abstract][Full Text] [Related]
14. Whole-body glucose metabolism in obese patients with type 2 diabetes mellitus: the impact of hypertension and strict blood glucose control.
Vestergaard H; Parving HH; Hansen L; Pedersen O
Diabet Med; 1995 Feb; 12(2):156-63. PubMed ID: 7743763
[TBL] [Abstract][Full Text] [Related]
15. Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes.
Hother-Nielsen O; Schmitz O; Andersen PH; Beck-Nielsen H; Pedersen O
Acta Endocrinol (Copenh); 1989 Mar; 120(3):257-65. PubMed ID: 2648723
[TBL] [Abstract][Full Text] [Related]
16. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
[TBL] [Abstract][Full Text] [Related]
17. In vivo insulin action and muscle glycogen synthase activity in type 2 (non-insulin-dependent) diabetes mellitus: effects of diet treatment.
Bak JF; Møller N; Schmitz O; Saaek A; Pedersen O
Diabetologia; 1992 Aug; 35(8):777-84. PubMed ID: 1511806
[TBL] [Abstract][Full Text] [Related]
18. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
[TBL] [Abstract][Full Text] [Related]
19. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus.
DeFronzo RA; Simonson D; Ferrannini E
Diabetologia; 1982 Oct; 23(4):313-9. PubMed ID: 6754515
[TBL] [Abstract][Full Text] [Related]
20. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
